HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.

13th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2026

October 19 -21, 2026 | Boston, Massachusetts, USA

Neuropharmacology and Novel Drug Development

Neuropharmacology and Novel Drug Development

The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology Conferences - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
INBC 2026 Speakers
Speaker at Brain Disorders Conference - Daniel Curry

Daniel Curry

Texas Children’s Hospital, United States
Speaker at Neuroscience Conference - Steven Benvenisti

Steven Benvenisti

Davis, Saperstein Salomon, PC, United States
Speaker at Neurology Conferences - Younok Dumortier Shin

Younok Dumortier Shin

OnusBio, United States
Speaker at Brain Disorders Conference - Jessica Marchant

Jessica Marchant

Texas Woman's University, United States
Tags

Submit your abstract Today

Watsapp